Biologic therapies for foot and ankle injuries

References

• Wei LC, Lei GH, Sheng PY, et al. Efficacy of platelet-rich plasma combined with allograft bone in the management of displaced intra-articular calcaneal fractures: a prospective cohort study. J Orthop Res. 2012;30(10):1570–1576.
   PubMed Web of Science ®Google Scholar
• Zhao E, Carney D, Chambers M, et al. The role of biologic in foot and ankle trauma-a review of the literature. Curr Rev Musculoskelet Med. 2018;11(3):495–502.
   PubMed Web of Science ®Google Scholar
• Shepherd DE, Seedhom BB. Thickness of human articular cartilage in joints of the lower limb. Ann Rheum Dis. 1999;58(1):27–34.
   PubMed Web of Science ®Google Scholar
• Kraeutler MJ, Kaenkumchorn T, Pascual-Garrido C, et al. Peculiarities in Ankle Cartilage. Cartilage. 2017;8(1):12–18.
   PubMed Web of Science ®Google Scholar
• Boswell SG, Schnabel LV, Mohammed HO, et al. Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons. Am J Sports Med. 2014;42(1):42–49.
   PubMed Web of Science ®Google Scholar
• Hall MP, Band PA, Meislin RJ, et al. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009;17(10):602–608.
   PubMed Web of Science ®Google Scholar
• Report. Platelet rich plasma (PRP) market analysis by product (pure, leukocyte-rich, leukocyte-rich fibrin), by application (orthopedics, cosmetic surgery, ophthalmic surgery, neurosurgery), and segment forecasts, 2014–2025. 2017.
   Google Scholar
• Global $647 Million Platelet Rich Plasma (PRP) Market Analysis 2014-2017 & Forecasts to 2025. 2018. [cited 2020 Jun 08]. Available from: https://www.prnewswire.com/news-releases/global-647-million-platelet-rich-plasma-prp-market-analysis-2014-2017--forecasts-to-2025-300489825.html.
   Google Scholar
• Alsousou J, Keene DJ, Hulley PA, et al. Platelet rich plasma in achilles tendon healing 2 (PATH-2) trial: protocol for a multicentre, participant and assessor-blinded, parallel-group randomised clinical trial comparing platelet-rich plasma (PRP) injection versus placebo injection for Achilles tendon rupture. BMJ Open. 2017;7(11):e018135.
   PubMed Web of Science ®Google Scholar
• Zhang J, Middleton KK, Fu FH, et al. HGF mediates the anti-inflammatory effects of PRP on injured tendons. PloS One. 2013;8(6):e67303.
   PubMed Web of Science ®Google Scholar
• Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappaB inhibition via HGF. J Cell Physiol. 2010;225(3):757–766.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang JH. Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. Am J Sports Med. 2010;38(12):2477–2486.
   PubMed Web of Science ®Google Scholar
• Scott A, LaPrade RF, Harmon KG, et al. Platelet-Rich Plasma for Patellar Tendinopathy: A Randomized Controlled Trial of Leukocyte-Rich PRP or Leukocyte-Poor PRP Versus Saline. Am J Sports Med. 2019;47(7):1654–1661.
   PubMed Web of Science ®Google Scholar
• Peerbooms JC, Sluimer J, Bruijn DJ, et al. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010;38(2):255–262.
   PubMed Web of Science ®Google Scholar
• Vetrano M, Castorina A, Vulpiani MC, et al. Platelet-rich plasma versus focused shock waves in the treatment of jumper’s knee in athletes. Am J Sports Med. 2013;41(4):795–803.
   PubMed Web of Science ®Google Scholar
• Dragoo JL, Wasterlain AS, Braun HJ, et al. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med. 2014;42(3):610–618.
   PubMed Web of Science ®Google Scholar
• Le ADK, Enweze L, DeBaun MR, et al. Current Clinical Recommendations for Use of Platelet-Rich Plasma. Curr Rev Musculoskelet Med. 2018;11(4):624–634.
   PubMed Web of Science ®Google Scholar
• Kon E, Filardo G, Delcogliano M, et al. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper’s knee. Injury. 2009;40(6):598–603.
   PubMed Web of Science ®Google Scholar
• Volpi P, Quaglia A, Schoenhuber H, et al. Growth factors in the management of sport-induced tendinopathies: results after 24 months from treatment. A pilot study. J Sports Med Phys Fitness. 2010;50(4):494–500.
   PubMed Web of Science ®Google Scholar
• Ferrero G, Fabbro E, Orlandi D, et al. Ultrasound-guided injection of platelet-rich plasma in chronic Achilles and patellar tendinopathy. J Ultrasound. 2012;15(4):260–266.
   PubMedGoogle Scholar
• Gosens T, Den Oudsten BL, Fievez E. Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments. Int Orthop. 2012;36(9):1941–1946.
   PubMed Web of Science ®Google Scholar
• Dallaudiere B, Pesquer L, Meyer P, et al. Intratendinous injection of platelet-rich plasma under US guidance to treat tendinopathy: a long-term pilot study. J Vasc Interv Radiol. 2014;25(5):717–723.
   PubMed Web of Science ®Google Scholar
• Kaux JF, Croisier JL, Bruyere O, et al. One injection of platelet-rich plasma associated to a submaximal eccentric protocol to treat chronic jumper’s knee. J Sports Med Phys Fitness. 2015;55(9):953–961.
   PubMed Web of Science ®Google Scholar
• Charousset C, Zaoui A, Bellaiche L, et al. Are multiple platelet-rich plasma injections useful for treatment of chronic patellar tendinopathy in athletes? A prospective study. Am J Sports Med. 2014;42(4):906–911.
   PubMed Web of Science ®Google Scholar
• van Ark M, van den Akker-scheek I, Meijer LT, et al. An exercise-based physical therapy program for patients with patellar tendinopathy after platelet-rich plasma injection. Phys Ther Sport. 2013;14(2):124–130.
   PubMed Web of Science ®Google Scholar
• Mautner K, Colberg RE, Malanga G, et al. Outcomes after ultrasound-guided platelet-rich plasma injections for chronic tendinopathy: a multicenter, retrospective review. Pm R. 2013;5(3):169–175.
   PubMedGoogle Scholar
• Gaweda K, Tarczynska M, Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int J Sports Med. 2010;31(8):577–583.
   PubMed Web of Science ®Google Scholar
• Owens RF Jr., Ginnetti J, Conti SF, et al. Clinical and magnetic resonance imaging outcomes following platelet rich plasma injection for chronic midsubstance Achilles tendinopathy. Foot Ankle Int. 2011;32(11):1032–1039.
   PubMed Web of Science ®Google Scholar
• Monto RR. Platelet rich plasma treatment for chronic Achilles tendinosis. Foot Ankle Int. 2012;33(5):379–385.
   PubMed Web of Science ®Google Scholar
• Deans VM, Miller A, Ramos J. A prospective series of patients with chronic Achilles tendinopathy treated with autologous-conditioned plasma injections combined with exercise and therapeutic ultrasonography. J Foot Ankle Surg. 2012;51(6):706–710.
   PubMed Web of Science ®Google Scholar
• Filardo G, Kon E, Di Matteo B, et al. Platelet-rich plasma injections for the treatment of refractory Achilles tendinopathy: results at 4 years. Blood Transfus. 2014;12(4):533–540.
   PubMed Web of Science ®Google Scholar
• Murawski CD, Smyth NA, Newman H, et al. A single platelet-rich plasma injection for chronic midsubstance achilles tendinopathy: a retrospective preliminary analysis. Foot Ankle Spec. 2014;7(5):372–376.
   PubMedGoogle Scholar
• de Vos RJ, Weir A, van Schie HT, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2):144–149.
   PubMed Web of Science ®Google Scholar
• Castricini R, Longo UG, De Benedetto M, et al. Platelet-rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. Am J Sports Med. 2011;39(2):258–265.
   PubMed Web of Science ®Google Scholar
• de Jonge S, de Vos RJ, Weir A, et al. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med. 2011;39(8):1623–1629.
   PubMed Web of Science ®Google Scholar
• Kon E, Filardo G, Di Martino A, et al. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc. 2011;19(4):516–527.
   PubMed Web of Science ®Google Scholar
• Andia I, Martin JI, Maffulli N. Advances with platelet rich plasma therapies for tendon regeneration. Expert Opin Biol Ther. 2018;18(4):389-398..
   Web of Science ®Google Scholar
• Castillo TN, Pouliot MA, Kim HJ, et al. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011;39(2):266–271.
   PubMed Web of Science ®Google Scholar
• Anitua E, Sanchez M, Nurden AT, et al. Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res A. 2006;77(2):285–293.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang J, Wu H, et al. The differential effects of leukocyte-containing and pure platelet-rich plasma (PRP) on tendon stem/progenitor cells - implications of PRP application for the clinical treatment of tendon injuries. Stem Cell Res Ther. 2015;6:173.
   PubMed Web of Science ®Google Scholar
• Dragoo JL, Braun HJ, Durham JL, et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med. 2012;40(6):1274–1281.
   PubMed Web of Science ®Google Scholar
• Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39(10):2135–2140.
   PubMed Web of Science ®Google Scholar
• Braun HJ, Kim HJ, Chu CR, et al. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. Am J Sports Med. 2014;42(5):1204–1210.
   PubMed Web of Science ®Google Scholar
• Wang JH. Can PRP effectively treat injured tendons? Muscles Ligaments Tendons J. 2014;4(1):35–37.
   PubMedGoogle Scholar
• Abate M, Di Gregorio P, Schiavone C, et al. Platelet rich plasma in tendinopathies: how to explain the failure. Int J Immunopathol Pharmacol. 2012;25(2):325–334.
   PubMed Web of Science ®Google Scholar
• Kannus P, Jozsa L. Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J Bone Joint Surg Am. 1991;73(10):1507–1525.
   PubMedGoogle Scholar
• Zhang J, Wang JH. PRP treatment effects on degenerative tendinopathy - an in vitro model study. Muscles Ligaments Tendons J. 2014;4(1):10–17.
   PubMedGoogle Scholar
• Finnoff JT, Fowler SP, Lai JK, et al. Treatment of chronic tendinopathy with ultrasound-guided needle tenotomy and platelet-rich plasma injection. Pm R. 2011;3(10):900–911.
   PubMedGoogle Scholar
• Monto RR. Platelet-rich plasma and plantar fasciitis. Sports Med Arthrosc Rev. 2013;21(4):220–224.
   PubMed Web of Science ®Google Scholar
• Monto RR. Platelet-rich plasma efficacy versus corticosteroid injection treatment for chronic severe plantar fasciitis. Foot Ankle Int. 2014;35(4):313–318.
   PubMed Web of Science ®Google Scholar
• Aksahin E, Dogruyol D, Yuksel HY, et al. The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis. Arch Orthop Trauma Surg. 2012;132(6):781–785.
   PubMed Web of Science ®Google Scholar
• Lopez-Gavito E, Gomez-Carlin LA, Parra-Tellez P, et al. Platelet-rich plasma for managing calcaneus tendon tendinopathy and plantar fasciitis. Acta Ortop Mex. 2011;25(6):380–385.
   PubMedGoogle Scholar
• Martinelli N, Marinozzi A, Carni S, et al. Platelet-rich plasma injections for chronic plantar fasciitis. Int Orthop. 2013;37(5):839–842.
   PubMed Web of Science ®Google Scholar
• Ragab EM, Othman AM. Platelets rich plasma for treatment of chronic plantar fasciitis. Arch Orthop Trauma Surg. 2012;132(8):1065–1070.
   PubMed Web of Science ®Google Scholar
• Kalaci A, Cakici H, Hapa O, et al. Treatment of plantar fasciitis using four different local injection modalities: a randomized prospective clinical trial. J Am Podiatr Med Assoc. 2009;99(2):108–113.
   PubMed Web of Science ®Google Scholar
• Acevedo JI, Beskin JL. Complications of plantar fascia rupture associated with corticosteroid injection. Foot Ankle Int. 1998;19(2):91–97.
   PubMed Web of Science ®Google Scholar
• Cohen IK, Diegelmann RF, Johnson ML. Effect of corticosteroids on collagen synthesis. Surgery. 1977;82(1):15–20.
   PubMed Web of Science ®Google Scholar
• Peerbooms JC, Lodder P, den Oudsten BL, et al. Positive effect of platelet-rich plasma on pain in plantar fasciitis: a double-blind multicenter randomized controlled trial. Am J Sports Med. 2019;47(13):3238–3246.
   PubMed Web of Science ®Google Scholar
• Hannon CP, Ross KA, Murawski CD, et al. Arthroscopic bone marrow stimulation and concentrated bone marrow aspirate for osteochondral lesions of the talus: a case-control study of functional and magnetic resonance observation of cartilage repair tissue outcomes. Arthroscopy. 2016;32(2):339–347.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang J, Yang J, et al. Kartogenin with PRP promotes the formation of fibrocartilage zone in the tendon-bone interface. J Tissue Eng Regen Med. 2017;11(12):3445–3456.
   PubMed Web of Science ®Google Scholar
• Gormeli G, Gormeli CA, Ataoglu B, et al. PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2017;25(3):958–965.
   PubMed Web of Science ®Google Scholar
• Guney A, Akar M, Karaman I, et al. Clinical outcomes of platelet rich plasma (PRP) as an adjunct to microfracture surgery in osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc. 2015;23(8):2384–2389.
   PubMed Web of Science ®Google Scholar
• Mei-Dan O, Carmont MR, Laver L, et al. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med. 2012;40(3):534–541.
   PubMed Web of Science ®Google Scholar
• Kawasaki K, Ochi M, Uchio Y, et al. Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol. 1999;179(2):142–148.
   PubMed Web of Science ®Google Scholar
• Pilichi S, Rocca S, Pool RR, et al. Treatment with embryonic stem-like cells into osteochondral defects in sheep femoral condyles. BMC Vet Res. 2014;10:301.
   PubMed Web of Science ®Google Scholar
• Kaplan LD, Lu Y, Snitzer J, et al. The effect of early hyaluronic acid delivery on the development of an acute articular cartilage lesion in a sheep model. Am J Sports Med. 2009;37(12):2323–2327.
   PubMed Web of Science ®Google Scholar
• Strauss E, Schachter A, Frenkel S, et al. The efficacy of intra-articular hyaluronan injection after the microfracture technique for the treatment of articular cartilage lesions. Am J Sports Med. 2009;37(4):720–726.
   PubMed Web of Science ®Google Scholar
• Shang XL, Tao HY, Chen SY, et al. Clinical and MRI outcomes of HA injection following arthroscopic microfracture for osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc. 2016;24(4):1243–1249.
   PubMed Web of Science ®Google Scholar
• Doral MN, Bilge O, Batmaz G, et al. Treatment of osteochondral lesions of the talus with microfracture technique and postoperative hyaluronan injection. Knee Surg Sports Traumatol Arthrosc. 2012;20(7):1398–1403.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yuan T, Zheng N, et al. The combined use of kartogenin and platelet-rich plasma promotes fibrocartilage formation in the wounded rat Achilles tendon entheses. Bone Joint Res. 2017;6(4):231–244.
   PubMed Web of Science ®Google Scholar
• Walden G, Liao X, Donell S, et al. Biological, and biomaterials perspective into tendon injuries and regeneration. Tissue Eng Part B Rev. 2017;23(1):44–58.
   PubMed Web of Science ®Google Scholar
• Kuo CK, Marturano JE, Tuan RS. Novel strategies in tendon and ligament tissue engineering: advanced biomaterials and regeneration motifs. Sports Med Arthrosc Rehabil Ther Technol. 2010;2:20.
   PubMedGoogle Scholar
• Zhang X, Wang J, Ren M, et al. A novel collagen/platelet-rich plasma (COL/PRP) scaffold: preparation and growth factor release analysis. Cell Tissue Bank. 2016;17(2):327–334.
   PubMed Web of Science ®Google Scholar
• Fang D, Jin P, Huang Q, et al. Platelet-rich plasma promotes the regeneration of cartilage engineered by mesenchymal stem cells and collagen hydrogel via the TGF-beta/SMAD signaling pathway. J Cell Physiol. 2019. DOI:10.1002/jcp.28211
   Web of Science ®Google Scholar
• Vavken P, Murray MM. The potential for primary repair of the ACL. Sports Med Arthrosc Rev. 2011;19(1):44–49.
   PubMed Web of Science ®Google Scholar
• Imam MA, Holton J, Horriat S, et al. A systematic review of the concept and clinical applications of bone marrow aspirate concentrate in tendon pathology. Sicot J. 2017;3:58.
   PubMed Web of Science ®Google Scholar
• Indino C, D’Ambrosi R, Usuelli FG. Biologics in the treatment of achilles tendon pathologies. Foot Ankle Clin. 2019;24(3):471–493.
   PubMed Web of Science ®Google Scholar
• Broese M, Toma I, Haasper C, et al. Seeding a human tendon matrix with bone marrow aspirates compared to previously isolated hBMSCs–an in vitro study. Technol Health Care. 2011;19(6):469–479.
   PubMed Web of Science ®Google Scholar
• Stein BE, Stroh DA, Schon LC. Outcomes of acute Achilles tendon rupture repair with bone marrow aspirate concentrate augmentation. Int Orthop. 2015;39(5):901–905.
   PubMed Web of Science ®Google Scholar
• Usuelli FG, Grassi M, Maccario C, et al. Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up. Knee Surg Sports Traumatol Arthrosc. 2018;26(7):2000–2010.
   PubMed Web of Science ®Google Scholar
• Behfar M, Sarrafzadeh-Rezaei F, Hobbenaghi R, et al. Adipose-derived stromal vascular fraction improves tendon healing in rabbits. Chin J Traumatol. 2011;14(6):329–335.
   PubMedGoogle Scholar
• de Aro AA, Carneiro GD, Teodoro LFR, et al. Injured achilles tendons treated with adipose-derived stem cells transplantation and GDF-5. Cells. 2018;7(9):127.
   Web of Science ®Google Scholar
• Heckmann N, Auran R, Mirzayan R. Application of amniotic tissue in orthopedic surgery. Am J Orthop (Belle Mead NJ). 2016;45(7):E421–e425.
   PubMedGoogle Scholar
• Zelen CM, Poka A, Andrews J. Prospective, randomized, blinded, comparative study of injectable micronized dehydrated amniotic/chorionic membrane allograft for plantar fasciitis–a feasibility study. Foot Ankle Int. 2013;34(10):1332–1339.
   PubMed Web of Science ®Google Scholar
• Adly OA, Moghazy AM, Abbas AH, et al. Assessment of amniotic and polyurethane membrane dressings in the treatment of burns. Burns. 2010;36(5):703–710.
   PubMed Web of Science ®Google Scholar
• Eslani M, Baradaran-Rafii A, Cheung AY, et al. Amniotic membrane transplantation in acute severe ocular chemical injury: a randomized clinical trial. Am J Ophthalmol. 2019;199:209–215.
   PubMed Web of Science ®Google Scholar
• Caruso M, Evangelista M, Parolini O. Human term placental cells: phenotype, properties and new avenues in regenerative medicine. Int J Mol Cell Med. 2012;1(2):64–74.
   PubMedGoogle Scholar
• Werber B. Amniotic tissues for the treatment of chronic plantar fasciosis and achilles tendinosis. J Sports Med (Hindawi Publ Corp). 2015;2015:219896.
   PubMedGoogle Scholar
• Hanselman AE, Tidwell JE, Santrock RD. Cryopreserved human amniotic membrane injection for plantar fasciitis: a randomized, controlled, double-blind pilot study. Foot Ankle Int. 2015;36(2):151–158.
   PubMed Web of Science ®Google Scholar
• McQuilling JP, Sanders M, Poland L, et al. Dehydrated amnion/chorion improves achilles tendon repair in a diabetic animal model. Wounds. 2019;31(1):19–25.
   PubMed Web of Science ®Google Scholar
• Kueckelhaus M, Philip J, Kamel RA, et al. Sustained release of amnion-derived cellular cytokine solution facilitates achilles tendon healing in rats. Eplasty. 2014;14:e29.
   PubMedGoogle Scholar
• Coban I, Satoğlu IS, Gültekin A, et al. Effects of human amniotic fluid and membrane in the treatment of Achilles tendon ruptures in locally corticosteroid-induced Achilles tendinosis: an experimental study on rats. Foot Ankle Surg. 2009;15(1):22–27.
   PubMedGoogle Scholar
• Adams SB Jr., Thorpe MA, Parks BG, et al. Stem cell-bearing suture improves Achilles tendon healing in a rat model. Foot Ankle Int. 2014;35(3):293–299.
   PubMed Web of Science ®Google Scholar
• Yao J, Woon CY, Behn A, et al. The effect of suture coated with mesenchymal stem cells and bioactive substrate on tendon repair strength in a rat model. J Hand Surg Am. 2012;37(8):1639–1645.
   PubMedGoogle Scholar
• Gissi C, Radeghieri A, Antonetti Lamorgese Passeri C. Extracellular vesicles from rat-bone-marrow mesenchymal stromal/stem cells improve tendon repair in rat Achilles tendon injury model in dose-dependent manner: A pilot study. PloS One. 2020;15(3):e0229914.
   PubMed Web of Science ®Google Scholar
• Webb WR, Dale TP, Lomas AJ, et al. The application of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds for tendon repair in the rat model. Biomaterials. 2013;34(28):6683–6694.
   PubMed Web of Science ®Google Scholar
• Ning LJ, Zhang Y, Chen XH, et al. Preparation and characterization of decellularized tendon slices for tendon tissue engineering. J Biomed Mater Res A. 2012;100(6):1448–1456.
   PubMedGoogle Scholar
• Farnebo S, Woon CY, Bronstein JA, et al. Decellularized tendon-bone composite grafts for extremity reconstruction: an experimental study. Plast Reconstr Surg. 2014;133(1):79–89.
   PubMed Web of Science ®Google Scholar
• Lohan A, Stoll C, Albrecht M, et al. Human hamstring tenocytes survive when seeded into a decellularized porcine Achilles tendon extracellular matrix. Connect Tissue Res. 2013;54(4–5):305–312.
   PubMed Web of Science ®Google Scholar
• Kimbrel EA, Kouris NA, Yavanian GJ, et al. Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev. 2014;23(14):1611–1624.
   PubMed Web of Science ®Google Scholar
• Toh WS, Lee EH, Cao T. Potential of human embryonic stem cells in cartilage tissue engineering and regenerative medicine. Stem Cell Rev Rep. 2011;7(3):544–559.
   PubMed Web of Science ®Google Scholar
• Cheng A, Kapacee Z, Peng J, et al. Cartilage repair using human embryonic stem cell-derived chondroprogenitors. Stem Cells Transl Med. 2014;3(11):1287–1294.
   PubMed Web of Science ®Google Scholar
• Grogan SP, Dorthé EW, Glembotski NE, et al. Cartilage tissue engineering combining microspheroid building blocks and microneedle arrays. Connect Tissue Res. 2020;61(2):229–243.
   PubMed Web of Science ®Google Scholar
• de Windt TS, Vonk LA, ICM S-C, et al. Allogeneic mesenchymal stem cells stimulate cartilage regeneration and are safe for single-stage cartilage repair in humans upon mixture with recycled autologous chondrons. Stem Cells. 2017;35(1):256–264.
   PubMed Web of Science ®Google Scholar
• Cottom JM, Plemmons BS. Bone marrow aspirate concentrate and its uses in the foot and ankle. Clin Podiatr Med Surg. 2018;35(1):19–26.
   PubMed Web of Science ®Google Scholar
• Harford JS, Dekker TJ, Adams SB. Bone marrow aspirate concentrate for bone healing in foot and ankle surgery. Foot Ankle Clin. 2016;21(4):839–845.
   PubMed Web of Science ®Google Scholar
• Fortier LA, Potter HG, Rickey EJ, et al. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am. 2010;92(10):1927–1937.
   PubMed Web of Science ®Google Scholar
• Buda R, Vannini F, Cavallo M, et al. One-step bone marrow-derived cell transplantation in talarosteochondral lesions: mid-term results. Joints. 2013;1(3):102–107.
   PubMedGoogle Scholar
• Kennedy JG, Murawski CD. The treatment of osteochondral lesions of the talus with autologous osteochondral transplantation and bone marrow aspirate concentrate: surgical technique. Cartilage. 2011;2(4):327–336.
   PubMed Web of Science ®Google Scholar
• Yasui Y, Ross AW, Kennedy JG, et al. Concentrated bone marrow aspirate in surgical treatment for osteochondral lesions of the talus. Foot Ankle Clin. 2016;21(4):869–884.
   PubMed Web of Science ®Google Scholar
• Kim YS, Park EH, Kim YC, et al. Clinical outcomes of mesenchymal stem cell injection with arthroscopic treatment in older patients with osteochondral lesions of the talus. Am J Sports Med. 2013;41(5):1090–1099.
   PubMed Web of Science ®Google Scholar
• Giannini S, Buda R, Battaglia M, et al. One-step repair in talar osteochondral lesions: 4-year clinical results and t2-mapping capability in outcome prediction. Am J Sports Med. 2013;41(3):511–518.
   PubMed Web of Science ®Google Scholar
• Giannini S, Buda R, Vannini F, et al. One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res. 2009;467(12):3307–3320.
   PubMed Web of Science ®Google Scholar
• Pierini M, Di Bella C, Dozza B, et al. The posterior iliac crest outperforms the anterior iliac crest when obtaining mesenchymal stem cells from bone marrow. J Bone Joint Surg Am. 2013;95(12):1101–1107.
   PubMedGoogle Scholar
• Murphy EP, Fenelon C, McGoldrick NP, et al. Bone marrow aspirate concentrate and microfracture technique for talar osteochondral lesions of the ankle. Arthrosc Tech. 2018;7(4):e391–e396.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lee HJ, Choi YJ, et al. Does an injection of a stromal vascular fraction containing adipose-derived mesenchymal stem cells influence the outcomes of marrow stimulation in osteochondral lesions of the talus? A clinical and magnetic resonance imaging study. Am J Sports Med. 2014;42(10):2424–2434.
   PubMed Web of Science ®Google Scholar
• Song Y, Du H, Dai C, et al. Human adipose-derived mesenchymal stem cells for osteoarthritis: a pilot study with long-term follow-up and repeated injections. Regen Med. 2018;13(3):295–307.
   PubMed Web of Science ®Google Scholar
• Peretti G, Ulivi M, de Girolamo L, et al. Evaluation of the use of autologous micro-fragmented adipose tissue in the treatment of knee osteoarthritis: preliminary results of a randomized controlled trial. J Biol Regul Homeost Agents. 2018;32:193–199.
   PubMedGoogle Scholar
• Shimozono Y, Dankert JF, Kennedy JG. Arthroscopic debridement and autologous micronized adipose tissue injection in the treatment of advanced-stage posttraumatic osteoarthritis of the ankle. Cartilage. 2020;1947603520946364. DOI:10.1177/1947603520946364
   Web of Science ®Google Scholar
• Usuelli FG, D’Ambrosi R, Maccario C, et al. Adipose-derived stem cells in orthopaedic pathologies. Br Med Bull. 2017;124(1):31–54.
   PubMed Web of Science ®Google Scholar
• Ho-Shui-Ling A, Bolander J, Rustom LE, et al. Bone regeneration strategies: engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives. Biomaterials. 2018;180:143–162.
   PubMed Web of Science ®Google Scholar
• Liras A. Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects. J Transl Med. 2010;8:131.
   PubMed Web of Science ®Google Scholar
• Gee A. Mesenchymal stem-cell therapy in a regulated environment. Cytotherapy. 2001;3(5):397–398.
   PubMed Web of Science ®Google Scholar
• Temple HT, Malinin TI. Orthobiologics in the Foot and Ankle. Foot Ankle Clin. 2016;21(4):809–823.
   PubMed Web of Science ®Google Scholar
• Malinin T, Temple HT, Buck BE. Transplantation of osteochondral allografts after cold storage. J Bone Joint Surg Am. 2006;88(4):762–770.
   PubMedGoogle Scholar
• Kwak SK, Kern BS, Ferkel RD, et al. Autologous chondrocyte implantation of the ankle: 2- to 10-year results. Am J Sports Med. 2014;42(9):2156–2164.
   PubMed Web of Science ®Google Scholar
• Giannini S, Buda R, Ruffilli A, et al. Arthroscopic autologous chondrocyte implantation in the ankle joint. Knee Surg Sports Traumatol Arthrosc. 2014;22(6):1311–1319.
   PubMed Web of Science ®Google Scholar
• Albano D, Martinelli N, Bianchi A, et al. Clinical and imaging outcome of osteochondral lesions of the talus treated using autologous matrix-induced chondrogenesis technique with a biomimetic scaffold. BMC Musculoskelet Disord. 2017;18(1):306.
   PubMedGoogle Scholar
• D’Ambrosi R, Maccario C, Serra N, et al. Osteochondral lesions of the talus and autologous matrix-induced chondrogenesis: is age a negative predictor outcome? Arthroscopy. 2017;33(2):428–435.
   PubMed Web of Science ®Google Scholar
• Richter M, Zech S. Matrix-associated stem cell transplantation (MAST) in chondral defects of foot and ankle is effective. Foot Ankle Surg. 2013;19(2):84–90.
   PubMed Web of Science ®Google Scholar
• Kanatli U, Eren A, Eren TK, et al. Single-step arthroscopic repair with cell-free polymer-based scaffold in osteochondral lesions of the talus: clinical and radiological results. Arthroscopy. 2017;33(9):1718–1726.
   PubMed Web of Science ®Google Scholar
• Valderrabano V, Miska M, Leumann A, et al. Reconstruction of osteochondral lesions of the talus with autologous spongiosa grafts and autologous matrix-induced chondrogenesis. Am J Sports Med. 2013;41(3):519–527.
   PubMed Web of Science ®Google Scholar
• Kaipel M, Schreiner M, Kellner R, et al. Beneficial clinical effects but limited tissue quality following osteochondral repair with a cell-free multilayered nano-composite scaffold in the talus. Foot Ankle Surg. 2017;23(4):302–306.
   PubMed Web of Science ®Google Scholar
• Anderson J, Swayzee Z. The use of human amniotic allograft on osteochondritis dissecans of the talar dome: a comparison with and without allografts in arthroscopically treated ankles. Surg Sci. 2015;06:412–417.
   Google Scholar
• Sarı E, Yalçınozan M, Polat B, et al. The effects of cryopreserved human amniotic membrane on fracture healing: animal study. Acta Orthop Traumatol Turc. 2019;53(6):485–489.
   PubMed Web of Science ®Google Scholar
• Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc. 2006;81(9):1241–1257.
   PubMed Web of Science ®Google Scholar
• Easley ME, Trnka HJ, Schon LC, et al. Isolated subtalar arthrodesis. J Bone Joint Surg Am. 2000;82(5):613–624.
   PubMedGoogle Scholar
• Hollinger JO, Hart CE, Hirsch SN, et al. Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am. 2008;90(Suppl 1):48–54.
   PubMedGoogle Scholar
• Daniels T, DiGiovanni C, Lau JT, et al. Prospective clinical pilot trial in a single cohort group of rhPDGF in foot arthrodeses. Foot Ankle Int. 2010;31(6):473–479.
   PubMed Web of Science ®Google Scholar
• Frey C, Halikus NM, Vu-Rose T, et al. A review of ankle arthrodesis: predisposing factors to nonunion. Foot Ankle Int. 1994;15(11):581–584.
   PubMed Web of Science ®Google Scholar
• Haddad SL, Coetzee JC, Estok R, et al. Intermediate and long-term outcomes of total ankle arthroplasty and ankle arthrodesis. A systematic review of the literature. J Bone Joint Surg Am. 2007;89(9):1899–1905.
   PubMed Web of Science ®Google Scholar
• DiGiovanni CW, Lin SS, Baumhauer JF, et al. Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/beta-TCP): an alternative to autogenous bone graft. J Bone Joint Surg Am. 2013;95(13):1184–1192.
   PubMedGoogle Scholar
• Daniels TR, Younger AS, Penner MJ, et al. Prospective randomized controlled trial of hindfoot and ankle fusions treated with rhPDGF-BB in combination with a β-TCP-collagen matrix. Foot Ankle Int. 2015;36(7):739–748.
   PubMed Web of Science ®Google Scholar
• Lin SS, Montemurro NJ, Krell ES. Orthobiologics in Foot and Ankle Surgery. J Am Acad Orthop Surg. 2016;24(2):113–122.
   PubMed Web of Science ®Google Scholar
• Citeroni MR, Ciardulli MC, Russo V, et al. In Vitro Innovation of Tendon Tissue Engineering Strategies. Int J Mol Sci. 2020;21:18.
   Web of Science ®Google Scholar
• Kraus TM, Imhoff FB, Reinert J, et al. Stem cells and bFGF in tendon healing: effects of lentiviral gene transfer and long-term follow-up in a rat Achilles tendon defect model. BMC Musculoskelet Disord. 2016;17:148.
   PubMed Web of Science ®Google Scholar
• Kraus TM, Imhoff FB, Wexel G, et al. Stem cells and basic fibroblast growth factor failed to improve tendon healing: an in vivo study using lentiviral gene transfer in a rat model. J Bone Joint Surg Am. 2014;96(9):761–769.
   PubMedGoogle Scholar
• Tokunaga T, Shukunami C, Okamoto N, et al. FGF-2 stimulates the growth of tenogenic progenitor cells to facilitate the generation of tenomodulin-positive tenocytes in a rat rotator cuff healing model. Am J Sports Med. 2015;43(10):2411–2422.
   PubMed Web of Science ®Google Scholar
• Usman MA, Nakasa T, Shoji T, et al. The effect of administration of double stranded MicroRNA-210 on acceleration of Achilles tendon healing in a rat model. J Orthop Sci. 2015;20(3):538–546.
   PubMed Web of Science ®Google Scholar
• Bibbo C, Anderson RB, Davis WH. Complications of midfoot and hindfoot arthrodesis. Clin Orthop Relat Res. 2001;391:45–58. DOI:10.1097/00003086-200110000-00007
   PubMed Web of Science ®Google Scholar
• Coughlin MJ, Grimes JS, Traughber PD, et al. Comparison of radiographs and CT scans in the prospective evaluation of the fusion of hindfoot arthrodesis. Foot Ankle Int. 2006;27(10):780–787.
   PubMed Web of Science ®Google Scholar
• Fourman MS, Borst EW, Bogner E, et al. Recombinant human BMP-2 increases the incidence and rate of healing in complex ankle arthrodesis. Clin Orthop Relat Res. 2014;472(2):732–739.
   PubMed Web of Science ®Google Scholar
• DeVries JG, Nguyen M, Berlet GC, et al. The effect of recombinant bone morphogenetic protein-2 in revision tibiotalocalcaneal arthrodesis: utilization of the retrograde arthrodesis intramedullary nail database. J Foot Ankle Surg. 2012;51(4):426–432.
   PubMed Web of Science ®Google Scholar
• Hreha J, Krell ES, Bibbo C. Role of recombinant human bone morphogenetic protein-2 on hindfoot arthrodesis. Foot Ankle Clin. 2016;21(4):793–802.
   PubMed Web of Science ®Google Scholar
• Daniels TR, Anderson J, Swords MP, et al. Recombinant human platelet-derived growth factor BB in combination with a beta-tricalcium phosphate (rhPDGF-BB/beta-TCP)-collagen matrix as an alternative to autograft. Foot Ankle Int. 2019;40(9):1068–1078.
   PubMed Web of Science ®Google Scholar
• Anderson JJ, Boone JJ, Hansen M, et al. Ankle arthrodesis fusion rates for mesenchymal stem cell bone allograft versus proximal tibia autograft. J Foot Ankle Surg. 2014;53(6):683–686.
   PubMed Web of Science ®Google Scholar
• Schneider M, Angele P, TAH J, et al. Rescue plan for Achilles: therapeutics steering the fate and functions of stem cells in tendon wound healing. Adv Drug Deliv Rev. 2018;129:352–375.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Pelled G, Turgeman G, et al. Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. J Clin Invest. 2006;116(4):940–952.
   PubMed Web of Science ®Google Scholar